This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval to move the manufacture of vitrax from the allergan facility in westport, ireland to the amo uppsala facility in sweden, for a 0. 4 ml fill volume in addition to the currently approved 0. 65 ml fill volume, and re-brand the dispersive vitrax product manufactured in uppsala, sweden as healon d (dispersive).
| Device | HEALON D |
| Classification Name | Aid, Surgical, Viscoelastic |
| Generic Name | Aid, Surgical, Viscoelastic |
| Applicant | ABBOTT MEDICAL OPTICS INC |
| Date Received | 2007-02-15 |
| Decision Date | 2008-08-22 |
| PMA | P880031 |
| Supplement | S014 |
| Product Code | LZP |
| Advisory Committee | Ophthalmic |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Change Design/components/specifications/material |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ABBOTT MEDICAL OPTICS INC 1700 E. St. Andrew Place santa Ana, CA 92705 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P880031 | Original Filing | |
| S016 | 2009-01-08 | Real-time Process |
| S015 | 2008-08-20 | 30-day Notice |
| S014 | 2007-02-15 | Normal 180 Day Track |
| S013 | 1999-10-15 | Real-time Process |
| S012 | 1998-02-02 | Real-time Process |
| S011 | 1995-12-26 | Normal 180 Day Track |
| S010 | 1995-11-24 | Normal 180 Day Track |
| S009 | 1995-10-17 | Normal 180 Day Track |
| S008 | 1994-06-02 | Special (immediate Track) |
| S007 | 1992-08-21 | Normal 180 Day Track |
| S006 | 1992-07-02 | Normal 180 Day Track |
| S005 | 1992-01-15 | Normal 180 Day Track |
| S004 | 1991-06-12 | Normal 180 Day Track |
| S003 | ||
| S002 | ||
| S001 |